Lewis J A, Davide J P, Melera P W
Proc Natl Acad Sci U S A. 1982 Nov;79(22):6961-5. doi: 10.1073/pnas.79.22.6961.
A series of antifolate-resistant Chinese hamster lung sublines that overproduce either a Mr 20,000 or a Mr 21,000 class of dihydrofolate reductase (DHFR; tetrahydrofolate dehydrogenase; 5,6,7,8-tetrahydrofolate:NADP+ oxidoreductase, EC 1.5.1.3), known to contain amplified DHFR genes, has been analyzed by DNA and RNA transfer techniques. The results suggest that the Mr 20,000 and Mr 21,000 DHFRs are encoded by at least two polymorphic DHFR genes, both of which are expressed in drug-sensitive parental cells. In drug-resistant sublines only one of the two DHFR gene types is amplified, thus accounting for the overproduction of one or the other molecular weight class of DHFR. In addition to the known differences between the DHFRs whose overproduction they direct, these allelic genes differ in restriction endonuclease profiles and in the relative abundances of their multiple mRNA transcripts.
一系列抗叶酸的中国仓鼠肺细胞亚系,这些亚系要么过量产生一种分子量为20,000的二氢叶酸还原酶(DHFR;四氢叶酸脱氢酶;5,6,7,8 - 四氢叶酸:NADP +氧化还原酶,EC 1.5.1.3),要么过量产生一种分子量为21,000的二氢叶酸还原酶,已知这些亚系含有扩增的DHFR基因,已通过DNA和RNA转移技术进行了分析。结果表明,分子量为20,000和21,000的DHFR由至少两个多态性DHFR基因编码,这两个基因在对药物敏感的亲本细胞中均有表达。在耐药亚系中,两种DHFR基因类型中只有一种被扩增,从而导致其中一种分子量类别的DHFR过量产生。除了它们所指导过量产生的DHFR之间已知的差异外,这些等位基因在限制性内切酶图谱以及它们多种mRNA转录本的相对丰度方面也存在差异。